Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    ICHTHYOSIS, X-LINKED
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  National Registry for Ichthyosis and Related Disorders
Conditions: Darier Disease;   Hailey-Hailey Disease;   Hyperkeratosis, Epidermolytic;   Ichthyosis;   Ichthyosis, Lamellar;   Ichthyosis, X-Linked;   Keratoderma
2 Recruiting STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Condition: Aortic Valve Stenosis
Intervention: Procedure: Transcatheter Aortic Valve Replacement
3 Terminated
Has Results
Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Conditions: Sarcoma;   Leiomyosarcoma;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Fibrous;   Histiocytoma/Undifferentiated Pleomorphic Sarcoma
Intervention: Drug: Gemcitabine and Docetaxel in Combination with Pazopanib
4 Completed Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)
Conditions: Gastrointestinal Stromal Tumors;   Soft Tissue Sarcomas
Intervention: Drug: IPI-504
5 Recruiting Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Pazopanib
6 Unknown  Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma (STS)
Intervention: Other: F18-FGD PET/CT
7 Terminated Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
Condition: Sarcoma
Interventions: Drug: Doxorubicin;   Drug: Trabectedin
8 Not yet recruiting Trabectedin Maintenance Post 1st-line in STS
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Trabectedin
9 Recruiting Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
Conditions: Alveolar Soft Part Sarcoma;   Soft Tissue Sarcomas
Interventions: Drug: Axitinib;   Drug: Pembrolizumab;   Procedure: Blood Draw;   Procedure: Tumor Specimen Collection
10 Recruiting STS/ACC TVT Registry Mitral Module
Condition: Mitral Valve Regurgitation
Intervention: Device: Leaflet Clip
11 Active, not recruiting A Phase II Study of Anlotinib in STS Patients
Condition: Cancer
Intervention: Drug: Anlotinib
12 Recruiting Preoperative vs Postoperative IMRT for Extremity/Truncal STS
Condition: Adult Soft Tissue Sarcoma
Interventions: Radiation: Preoperative intensity modulated radiation therapy;   Radiation: Postoperative intensity modulated radiation therapy
13 Completed Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Bendamustin
14 Recruiting Study of Anlotinib in Patients With Soft Tissue Sarcoma(STS)(ALTER0203)
Condition: Soft Tissue Sarcoma
Interventions: Drug: Anlotinib;   Drug: Placebo
15 Unknown  Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Trofosfamide
16 Completed
Has Results
Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
Condition: Soft Tissue Sarcoma
Interventions: Procedure: External Beam Radiation Therapy (RT);   Biological: Autologous Dendritic Cells
17 Not yet recruiting Ph II Nintedanib or Intravenous Ifosfamide Advanced Metastatic STS Failed on Imatinib and Sunitinib
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Nintedanib;   Drug: Ifosfamide
18 Completed Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Carboplatin
19 Unknown  Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
Condition: Soft Tissue Sarcoma
20 Completed Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
Condition: Soft Tissue Sarcoma
Intervention: Drug: Vorinostat

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years